Ticker Details
Liquidia Technologies, Inc.
IPO Date:	July 23, 2018
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$3.55B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.35 | 3.36%
Avg Daily Range (30 D):	$0.97 | 2.73%
Avg Daily Range (90 D):	$1.09 | 3.02%

Institutional Daily Volume
Avg Daily Volume:	.75M
Avg Daily Volume (30 D):	1.14M
Avg Daily Volume (90 D):	1.42M

Trade Size
Avg Trade Size (Sh.):	96
Avg Trade Size (Sh.) (30 D):	53
Avg Trade Size (Sh.) (90 D):	60

Institutional Trades
Total Institutional Trades:	1,105
Avg Institutional Trade:	$2.13M
Avg Institutional Trade (30 D):	$3.24M
Avg Institutional Trade (90 D):	$2.87M
Avg Institutional Trade Volume:	.13M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.72M
Avg Closing Trade (30 D):	$4.9M
Avg Closing Trade (90 D):	$4.88M
Avg Closing Volume:	160.7K

News

Apr 8, 2026 @ 5:00 PM Interstitial Lung Disease Market to Witness Accele... Source: Delveinsight

Apr 5, 2026 @ 2:06 PM Liquidia's Chairman Sold Company Shares Worth $2.5... Source: Robert Izquierdo

Mar 28, 2026 @ 3:26 PM The Chief Commercial Officer of Liquidia (LQDA) So... Source: Cory Renauer

Sep 29, 2025 @ 12:30 PM Liquidia to Present Clinical Data from ASCENT Tria... Source: Globe Newswire

Aug 14, 2025 @ 5:00 PM Pulmonary Hypertension associated with Interstitia... Source: Delveinsight

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.8	$.17	$-.8
Diluted EPS	$-.8	$.17	$-.8
Revenue	$158.32M	$92.02M	$158.32M
Gross Profit
Net Income / Loss	$-68.92M	$14.56M	$-68.92M
Operating Income / Loss	$-51.38M	$19.79M	$-51.38M
Cost of Revenue
Net Cash Flow	$17.71M	$33.18M	$17.71M
PE Ratio